_version_ 1784760100852858880
author Bojkova, Denisa
Stack, Richard
Rothenburger, Tamara
Kandler, Joshua D.
Ciesek, Sandra
Wass, Mark N.
Michaelis, Martin
Cinatl, Jindrich
author_facet Bojkova, Denisa
Stack, Richard
Rothenburger, Tamara
Kandler, Joshua D.
Ciesek, Sandra
Wass, Mark N.
Michaelis, Martin
Cinatl, Jindrich
author_sort Bojkova, Denisa
collection PubMed
description
format Online
Article
Text
id pubmed-9339084
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The British Infection Association. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-93390842022-08-01 Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants Bojkova, Denisa Stack, Richard Rothenburger, Tamara Kandler, Joshua D. Ciesek, Sandra Wass, Mark N. Michaelis, Martin Cinatl, Jindrich J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2022-11 2022-07-31 /pmc/articles/PMC9339084/ /pubmed/35917841 http://dx.doi.org/10.1016/j.jinf.2022.07.023 Text en © 2022 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Bojkova, Denisa
Stack, Richard
Rothenburger, Tamara
Kandler, Joshua D.
Ciesek, Sandra
Wass, Mark N.
Michaelis, Martin
Cinatl, Jindrich
Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants
title Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants
title_full Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants
title_fullStr Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants
title_full_unstemmed Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants
title_short Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants
title_sort synergism of interferon-beta with antiviral drugs against sars-cov-2 variants
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339084/
https://www.ncbi.nlm.nih.gov/pubmed/35917841
http://dx.doi.org/10.1016/j.jinf.2022.07.023
work_keys_str_mv AT bojkovadenisa synergismofinterferonbetawithantiviraldrugsagainstsarscov2variants
AT stackrichard synergismofinterferonbetawithantiviraldrugsagainstsarscov2variants
AT rothenburgertamara synergismofinterferonbetawithantiviraldrugsagainstsarscov2variants
AT kandlerjoshuad synergismofinterferonbetawithantiviraldrugsagainstsarscov2variants
AT cieseksandra synergismofinterferonbetawithantiviraldrugsagainstsarscov2variants
AT wassmarkn synergismofinterferonbetawithantiviraldrugsagainstsarscov2variants
AT michaelismartin synergismofinterferonbetawithantiviraldrugsagainstsarscov2variants
AT cinatljindrich synergismofinterferonbetawithantiviraldrugsagainstsarscov2variants